Your patients’ well‑being is at the centre of everything pharmacy teams do and incorporating evidence-informed practice (EIP) into your daily practice helps you provide the best possible care. By using current, reliable evidence alongside your clinical expertise and your patients’ preferences, you strengthen your clinical reasoning and can make informed decisions that support safe, effective, and person‑centred care.
The prescribed learning activity for pharmacists for the 2026-27 Continuing Competence Program (CCP) cycle is focused on EIP and how it benefits patient care, and it is now available in Academy.
Completing this prescribed learning activity is required of all pharmacists by the end of the 2026-27 CCP cycle. The activity is accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) and pharmacists can claim up to 2.0 accredited continuing education units (CEUs) upon completion.
The module complements and further expands on concepts introduced in the Advice to Professions: Evidence-informed practice for pharmacy professionals, which was published in May 2026.
The prescribed learning activity explores several concepts within EIP, including how to interpret and apply relevant standards of practice using a systematic, five-step process as described in the Advice to the Professions above.
What is EIP?
In your clinical practice, you make decisions every day that affect patient care. The Standards of Practice for Pharmacists and Pharmacy Technicians (SPPPT) require pharmacists to use EIP when making patient-care decisions. As described in the SPPPT, EIP helps you approach and support these decisions by integrating the best available evidence from research findings; your clinical expertise; and your patient’s preferences, values, and circumstances.
You may also hear this practice referred to as evidence-based medicine (EBM) and see the two terms used interchangeably.
